# A Study of ONO-7018 in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma

> **NCT06622226** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Ono Pharmaceutical Co., Ltd.** · enrollment: 24 (estimated)

## Conditions studied

- Non Hodgkin Lymphoma

## Interventions

- **DRUG:** ONO-7018

## Key facts

- **NCT ID:** NCT06622226
- **Lead sponsor:** Ono Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-11-27
- **Primary completion:** 2027-07-31
- **Final completion:** 2029-12-31
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2025-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06622226

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06622226, "A Study of ONO-7018 in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT06622226. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*